Study Design
Understanding
RCTs
Take Home Message: Randomization,
allocation concealment, and blinded outcome assessment help readers
judge whether a trial’s treatment effect is credible and applicable.
How to
Read a Meta-Analysis
Take Home Message:
Interpret pooled effects alongside study quality, heterogeneity, and
confidence intervals before applying a meta-analysis to patient
care.
Sedation
Daily
interruption of sedation
Take Home Message:
Daily interruption of continuous sedative infusions shortened mechanical
ventilation and ICU stay compared with clinician-directed interruption
in this single-center trial.
SLEAP
Take Home Message: Adding daily sedation interruption to
protocolized light sedation did not shorten time to extubation and
increased sedative exposure and nursing workload.
MIND-USA
Take Home Message: Haloperidol and ziprasidone did not increase
days alive without delirium or coma compared with placebo in critically
ill patients with acute respiratory failure or shock.
NONSEDA
Take Home Message: A strategy of no sedation did not improve
90-day survival compared with light sedation with daily interruption in
mechanically ventilated patients.
MENDS-2
Take Home Message: Dexmedetomidine and propofol produced
similar days alive without delirium or coma in mechanically ventilated
adults with sepsis managed with light sedation.
AID-ICU
(2023)
Take Home Message: Haloperidol did not
significantly increase days alive and out of hospital at 90 days in ICU
patients with delirium, despite lower mortality in a secondary
analysis.
Stroke
DAWN
Take Home Message: Thrombectomy improved 90-day functional
outcomes in selected patients with anterior-circulation large-vessel
stroke and a clinical-imaging mismatch presenting 6 to 24 hours after
last known well.
DESTINY
(hemicrani)
Take Home Message: Early
decompressive hemicraniectomy improved survival after malignant middle
cerebral artery infarction, but this small trial did not establish a
significant benefit for its primary functional endpoint.
RESCUE
Japan
Take Home Message: Endovascular therapy
improved functional outcomes in selected patients with large ischemic
cores, while increasing intracranial hemorrhage.
Resuscitation after Cardiac Arrest
HACA
Take Home Message: Cooling to 32–34°C improved neurologic
outcomes and reduced mortality compared with the usual care of that era
after witnessed ventricular-fibrillation cardiac arrest.
TTM
Take Home Message: Targeting 33°C did not improve survival or
neurologic outcomes compared with 36°C after out-of-hospital cardiac
arrest.
TTM2
Take Home Message: Targeting 33°C did not improve survival or
functional outcomes compared with targeted normothermia and early fever
treatment after out-of-hospital cardiac arrest.
HYPERION
Take Home Message: Targeting 33°C modestly increased survival
with favorable neurologic function at 90 days after nonshockable cardiac
arrest, without a significant mortality benefit.
CAPITAL
CHILL
Take Home Message: Cooling to 31°C did
not improve the composite of death or poor neurologic outcome compared
with 34°C after out-of-hospital cardiac arrest.
ARREST
Take Home Message: An ECMO-facilitated resuscitation strategy
improved survival to hospital discharge after refractory ventricular
fibrillation in this small, single-center trial stopped early.
Tracheal
intubation and survival
Take Home Message:
Tracheal intubation during in-hospital cardiac arrest was associated
with lower survival in a time-matched observational analysis, which
cannot establish causation.
INCEPTION
Take Home Message: Early extracorporeal CPR did not
significantly improve 30-day survival with favorable neurologic function
compared with conventional CPR in refractory out-of-hospital arrest.
Postop CT Surgery and Mechanical Circulatory Support
MOMENTUM
3
Take Home Message: The fully magnetically
levitated HeartMate 3 improved two-year survival free of disabling
stroke or pump replacement compared with the axial-flow HeartMate
II.
Rate vs
rhythm control for a.fib. after cardiac surgery
Take Home Message: Rate and rhythm control produced similar
hospital days and clinical outcomes in hemodynamically stable patients
with new atrial fibrillation after cardiac surgery.
VANCS
Take Home Message: Vasopressin reduced the composite of death
or severe complications compared with norepinephrine for
postcardiac-surgery vasoplegic shock in this single-center trial.
ADVOR
Take Home Message: Adding intravenous acetazolamide to loop
diuretics increased successful early decongestion in acute heart failure
without a demonstrated reduction in death or heart-failure
readmission.
DanGer
Shock
Take Home Message: A microaxial flow
pump reduced 180-day mortality in selected patients with STEMI-related
cardiogenic shock but increased serious adverse events and
renal-replacement therapy.
Resuscitation/Sepsis
Goal-directed sepsis resuscitation
EGDT (Rivers
et al)
Take Home Message: Early goal-directed
therapy reduced in-hospital mortality compared with usual care in this
single-center trial of severe sepsis and septic shock.
PROCESS
Take Home Message: Protocol-based early goal-directed therapy
did not improve survival compared with other protocolized care or
contemporary usual care in septic shock.
ProMISe
Take Home Message: Early goal-directed therapy did not improve
90-day survival compared with contemporary usual care for septic shock
and increased treatment intensity and costs.
ARISE
Take Home Message: Early goal-directed therapy did not improve
90-day survival compared with contemporary usual care for early septic
shock.
MAP Targets/Vasopressor Strategies
SEPSISPAM
Take Home Message: Targeting a MAP of 80–85 rather than 65–70
mm Hg did not improve septic-shock survival and increased atrial
fibrillation, although patients with chronic hypertension required less
dialysis.
65
trial
Take Home Message: A MAP target of 60–65
mm Hg reduced vasopressor exposure without a statistically significant
difference in 90-day mortality among older patients with vasodilatory
hypotension.
ANDROMEDA-SHOCK
Take Home Message: Capillary-refill-guided resuscitation did
not significantly reduce the primary outcome of 28-day mortality
compared with lactate-guided resuscitation in septic shock.
VASST
Take Home Message: Low-dose vasopressin did not significantly
reduce overall mortality compared with norepinephrine in patients with
septic shock.
Association
Between US Norepinephrine Shortage and Mortality
Take Home Message: A US norepinephrine shortage was associated
with increased septic-shock mortality and greater use of alternative
vasopressors, without establishing which substitution caused harm.
IV Fluid Volume Management
FEAST
Take Home Message: Albumin or saline boluses increased
mortality compared with no bolus in African children with severe febrile
illness and impaired perfusion, limiting extrapolation to other
settings.
Low vs
high volume meta-analysis
Take Home Message:
This meta-analysis found very low-certainty evidence and no clear
mortality difference between lower and higher initial fluid volumes in
adults with sepsis.
CLASSIC
Take Home Message: Restricting intravenous fluids after initial
resuscitation did not reduce 90-day mortality compared with standard
fluid therapy in ICU patients with septic shock.
CLOVERS
Take Home Message: An early restrictive-fluid strategy
prioritizing vasopressors did not improve survival compared with a
liberal-fluid strategy for sepsis-induced hypotension after initial
fluids.
IV Fluid Choice
SAFE
Take Home Message: Albumin and saline produced similar overall
28-day mortality in a broad ICU population, without establishing
equivalence in every diagnostic subgroup.
SMART
Take Home Message: Balanced crystalloids modestly reduced the
composite of death, new dialysis, or persistent renal dysfunction
compared with saline in critically ill adults.
CRISTAL
Take Home Message: Colloids did not significantly reduce the
primary outcome of 28-day mortality compared with crystalloids in
hypovolemic shock, despite a secondary 90-day survival signal.
ALBIOS
Take Home Message: Adding albumin to crystalloids did not
improve 28- or 90-day survival overall in patients with severe sepsis or
septic shock.
HES
vs. saline
Take Home Message: Hydroxyethyl
starch did not improve survival compared with saline and increased the
use of renal-replacement therapy in critically ill patients.
FLUID
Take Home Message: Hospital-wide use of lactated Ringer’s
rather than saline did not significantly reduce death or hospital
readmission within 90 days.
Adjunct Shock Therapy: Steroids, HAT, Vitamin C
Original
Annane trial
Take Home Message: Hydrocortisone
plus fludrocortisone reduced mortality in the prespecified subgroup of
septic-shock patients who did not respond to corticotropin in this
trial.
CORTICUS
Take Home Message: Hydrocortisone hastened shock reversal but
did not improve survival in septic shock, including among patients
without a corticotropin response.
ADRENAL
Take Home Message: Hydrocortisone accelerated shock resolution
but did not reduce 90-day mortality in mechanically ventilated patients
with septic shock.
APROCCHSS
Take Home Message: Hydrocortisone plus fludrocortisone reduced
90-day mortality compared with placebo in patients with septic
shock.
VITAMINS
Take Home Message: Adding vitamin C and thiamine to
hydrocortisone did not increase time alive and free of vasopressors
compared with hydrocortisone alone in septic shock.
LOVIT
(Vitamin C)
Take Home Message: Intravenous
vitamin C increased the risk of death or persistent organ dysfunction at
28 days in adults with sepsis receiving vasopressors.
Evaluation of Etomidate
use and association with mortality compared with ketamine among
critically ill patients
Take Home Message:
Etomidate use at initiation of invasive ventilation was associated with
higher hospital mortality than ketamine in this observational study,
which cannot establish causation.
Respiratory support/ARDS Care
Lung-protective Ventilation
ARMA
Take Home Message: Ventilation with approximately 6 rather than
12 mL/kg predicted body weight reduced mortality in acute lung injury
and ARDS.
ALVEOLI
Take Home Message: Higher and lower PEEP strategies produced
similar survival and ventilator-free days when both used low tidal
volumes in acute lung injury and ARDS.
EPVent-2
Take Home Message: Esophageal-pressure-guided PEEP did not
improve the composite of death and ventilator-free days compared with an
empirical high-PEEP strategy in moderate-to-severe ARDS.
PROSEVA
Take Home Message: Early prolonged prone positioning
substantially reduced mortality in patients with severe ARDS receiving
lung-protective ventilation.
ACURASYS
Take Home Message: Early 48-hour cisatracurium improved
adjusted 90-day survival in severe ARDS, although the unadjusted
mortality difference was not statistically significant.
ROSE
Take Home Message: Routine early neuromuscular blockade with
deep sedation did not improve 90-day survival compared with usual care
using lighter sedation in moderate-to-severe ARDS.
LUNG
SAFE
Take Home Message: ARDS was common,
frequently underrecognized, and often managed without recommended
protective strategies in this international observational study.
VV ECMO
CESAR
Take Home Message: Referral to an ECMO-capable center improved
six-month survival without severe disability in severe respiratory
failure, although the trial tested a care strategy rather than ECMO
alone.
EOLIA
Take Home Message: Early VV ECMO did not significantly reduce
the primary outcome of 60-day mortality in very severe ARDS, with
substantial crossover to rescue ECMO.
Bayesian
analysis of EOLIA
Take Home Message: A post
hoc Bayesian analysis suggested a high probability of mortality benefit
from early ECMO in very severe ARDS, with the estimate dependent on
prior assumptions.
Weaning and Post-extubation Care
TRAC
MAN
Take Home Message: Early tracheostomy did
not improve 30-day survival compared with a deferred strategy, and many
patients in the deferred group never required tracheostomy.
Postextubation
HFNC/NIV
Take Home Message: Prophylactic NIV
alternating with high-flow nasal oxygen reduced reintubation compared
with high-flow nasal oxygen alone in patients at high risk of extubation
failure.
TEAM
Take Home Message: Increasing early active mobilization during
mechanical ventilation did not improve days alive and out of hospital
and increased adverse events.
FAST
Take Home Message: Neither more frequent readiness screening
nor pressure-supported rather than T-piece spontaneous breathing trials
independently shortened time to successful extubation, with an
unexpected interaction between interventions.
Oxygenation Targets
HOT-ICU
Take Home Message: Targeting a PaO2 of 60 rather than 90 mm Hg
did not reduce 90-day mortality in adults with acute hypoxemic
respiratory failure.
Oxygen-ICU
Take Home Message: Conservative oxygen therapy reduced ICU
mortality in this single-center trial stopped early, leaving substantial
uncertainty about the size and generalizability of benefit.
ICU
ROX
Take Home Message: Conservative oxygen
therapy did not increase ventilator-free days compared with usual oxygen
therapy in mechanically ventilated adults.
BOX
Take Home Message: Restrictive and liberal oxygen targets
produced similar rates of death or severe neurologic disability after
out-of-hospital cardiac arrest.
PILOT
Take Home Message: Lower, intermediate, and higher
oxygen-saturation targets produced similar ventilator-free days in
mechanically ventilated adults.
Nutrition/GI
TARGET
Take Home Message: Energy-dense enteral nutrition increased
calorie delivery but did not improve 90-day survival in mechanically
ventilated adults.
PERMIT
Take Home Message: Permissive underfeeding and standard enteral
feeding produced similar 90-day mortality when protein intake was
comparable.
EPANIC
Take Home Message: Deferring supplemental parenteral nutrition
until day 8 led to faster recovery and fewer infections than starting it
early in critically ill adults.
EDEN
Take Home Message: Initial trophic and full enteral feeding
produced similar ventilator-free days and survival in acute lung injury,
with less gastrointestinal intolerance during trophic feeding.
Supplementary
parenteral nutrition trial
Take Home Message:
Supplemental parenteral nutrition on days 4–8 reduced subsequent
nosocomial infections in selected ICU patients whose enteral intake
remained below target.
SUP-ICU
Take Home Message: Pantoprazole reduced clinically important
gastrointestinal bleeding but did not improve 90-day survival in ICU
patients at risk of gastrointestinal bleeding.
PEPTIC
Take Home Message: A proton-pump-inhibitor strategy reduced
clinically important upper gastrointestinal bleeding compared with H2
blockers but did not significantly reduce hospital mortality.
Renal Failure and Dialysis
AKIKI
Take Home Message: An early dialysis strategy did not improve
60-day survival in severe AKI without urgent indications, and many
patients assigned to delay avoided dialysis.
STARRT-AKI
Take Home Message: Accelerated renal-replacement therapy did
not improve 90-day survival and increased dialysis dependence among
survivors compared with a standard strategy in severe AKI.
IDEAL-ICU
Take Home Message: Early renal-replacement therapy did not
improve 90-day survival compared with a delayed strategy in septic shock
with severe AKI, and the trial stopped early for futility.
RENAL
Take Home Message: Higher-intensity continuous
renal-replacement therapy did not improve 90-day survival compared with
a lower-intensity regimen in critically ill patients with AKI.
AKIKI2
Take Home Message: Further postponing dialysis beyond an
already delayed strategy did not increase dialysis-free days and raised
concern for increased mortality in severe AKI.
PLUS
Take Home Message: Balanced multielectrolyte solution did not
reduce 90-day mortality or new renal-replacement therapy compared with
saline in critically ill adults.
ICRAKI
(2026): Intermittent or Continuous Renal-Replacement Therapy in Acute
Kidney Injury
Take Home Message: Initial
intermittent hemodialysis failed to establish noninferiority to
continuous therapy for 90-day major adverse kidney events and was
associated with higher mortality in this trial stopped early.
Transfusion
TRICS
III
Take Home Message: A restrictive
transfusion threshold of 7.5 g/dL was noninferior to a liberal strategy
for death or major organ complications after cardiac surgery.
FOCUS
Take Home Message: A liberal transfusion threshold of 10 g/dL
did not improve survival or walking independence compared with a
restrictive strategy after hip-fracture surgery in patients with
cardiovascular risk.
TRISS
Take Home Message: A hemoglobin threshold of 7 rather than 9
g/dL reduced transfusions without a significant difference in 90-day
mortality among patients with septic shock.
Transfusion
strategies in upper GI bleeding
Take Home
Message: A restrictive transfusion threshold of 7 rather than 9
g/dL improved six-week survival and reduced rebleeding in selected
patients with acute upper gastrointestinal bleeding.
REALITY
Take Home Message: Restrictive transfusion met the trial’s
noninferiority criterion for 30-day major cardiovascular events in acute
myocardial infarction with anemia, but the confidence interval allowed
clinically important harm.
PROPPR
Take Home Message: A 1:1:1 plasma:platelet:red-cell ratio did
not significantly reduce overall mortality versus 1:1:2 in severe trauma
but improved hemostasis and reduced early exsanguination deaths.
Endocrine
NICE
SUGAR
Take Home Message: Intensive glucose
control targeting 81–108 mg/dL increased mortality and severe
hypoglycemia compared with conventional control in critically ill
adults.
Infectious Disease
STOP-IT
Take Home Message: About four days of antibiotics after
adequate source control produced similar outcomes to a longer course for
complicated intra-abdominal infection.
MERINO
Take Home Message: Piperacillin-tazobactam failed to
demonstrate noninferiority to meropenem for 30-day mortality in
ceftriaxone-resistant E. coli or Klebsiella bloodstream infection.
PROGRESS
Take Home Message: Procalcitonin-guided antibiotic
discontinuation reduced antibiotic duration and infection-associated
adverse events in sepsis in this randomized trial.
Palliative Care
RCT of
family-support intervention in ICUs
Take Home
Message: A structured ICU family-support intervention improved
perceived communication and patient-centeredness but did not reduce
surrogate decision-makers’ anxiety and depression at six months.
Healthcare Disparities in Critical Illness
Association
of Race and Ethnicity with COVID-19 Test Positivity and Hospitalization
Is Mediated by Socioeconomic Factors
Take Home
Message: Socioeconomic factors substantially mediated associations
between race or ethnicity and COVID-19 test positivity and
hospitalization in this observational study.
Racial bias in
pulse oximetry
Take Home Message: Pulse
oximetry missed arterial hypoxemia more often in Black than White
patients in two retrospective cohorts, revealing an important limitation
of oxygen-saturation monitoring.
Patient
and Hospital Factors Associated With Differences in Mortality Rates
Among Black and White US Medicare Beneficiaries Hospitalized With
COVID-19 Infection
Take Home Message:
Differences between hospitals largely accounted for the adjusted
Black–White disparity in death or hospice discharge among Medicare
patients hospitalized with COVID-19.
Temporal
Trends in Critical Care Outcomes in U.S. Minority-Serving
Hospitals
Take Home Message: Mortality
improvements were smaller in minority-serving ICUs than in other
hospitals over a decade, especially for Black patients, in this
observational cohort.
Racial
Variation in End-of-Life Intensive Care Use: A Race or Hospital
Effect?
Take Home Message: Most observed
racial and ethnic differences in end-of-life ICU use reflected which
hospitals patients attended rather than differences within the same
hospital.
Genetic
misdiagnoses and the potential for health disparities
Take Home Message: Underrepresentation of people with African
ancestry in genetic reference datasets contributed to misclassification
of benign variants as pathogenic, illustrating how unrepresentative data
can cause diagnostic inequity.